Sesamin, a sesame lignan, as a potent serum lipid-lowering food component

被引:19
|
作者
Ide, T [1 ]
Kushiro, M
Takahashi, Y
Shinohara, K
Fukuda, N
Sirato-Yasumoto, S
机构
[1] Natl Food Res Inst, Div Food Funct, Tsukuba, Ibaraki 3058642, Japan
[2] Miyazaki Univ, Fac Agr, Dept Biochem & Appl Biosci, Miyazaki 8892912, Japan
[3] Natl Inst Crop Sci, Dept Field Crop Res, Tsukuba, Ibaraki 3058518, Japan
来源
JARQ-JAPAN AGRICULTURAL RESEARCH QUARTERLY | 2003年 / 37卷 / 03期
关键词
sesame; fatty acid oxidation; fatty acid synthesis; lipoprotein production; rat;
D O I
10.6090/jarq.37.151
中图分类号
S [农业科学];
学科分类号
09 ;
摘要
Effect of sesamin, a sesame lignan, on the hepatic fatty acid metabolism was examined in the rat. Increase of the dietary level of sesamin progressively increased the mitochondrial and peroxisomal fatty acid oxidation rate. Mitochondrial activity almost doubled in rats fed a 0.5% sesamin diet. Peroxisomal activity became more than 10 times higher in rats fed a 0.5% sesamin diet, compared to those fed a sesamin-free diet. Dietary sesamin also markedly increased the hepatic activity and mRNA levels of various fatty acid oxidation enzymes. In contrast, dietary sesamin decreased the hepatic activity and mRNA abundance of lipogenic enzymes. This was associated with the down-regulation of sterol regulatory element-binding protein-1, a transcriptional factor that regulates the lipogenic enzyme gene expression. Dietary sesamin significantly decreased the triacylglycerol secretion accompanying the increase in ketone body production by the perfused rat liver. It is apparent that sesamin affects the fatty acid metabolism and lipoprotein production in the liver, and hence lowers the serum lipid levels. We also developed several sesame lines with seeds containing sesamin and sesamolin at twice the concentration of conventional cultivars. Compared to a conventional cultivar, these lignan-rich sesame seeds increased the hepatic fatty acid oxidation rate and lowered the serum triacylglycerol level in the rat. Therefore, it is considered that enrichment of the lignans potentiates the characteristics of sesame in improving human health.
引用
收藏
页码:151 / 158
页数:8
相关论文
共 50 条
  • [31] More Potent Lipid-Lowering Effect by Rosuvastatin Compared With Fluvastatin in Everolimus-Treated Renal Transplant Recipients
    Robertsen, Ida
    Asberg, Anders
    Granseth, Tone
    Vethe, Nils Tore
    Akhlaghi, Fatemeh
    Ghareeb, Mwlod
    Molden, Espen
    Reier-Nilsen, Morten
    Holdaas, Hallvard
    Midtvedt, Karsten
    TRANSPLANTATION, 2014, 97 (12) : 1266 - 1271
  • [32] Molecular hybridization method for obtaining paeonol-based fibrate derivatives with potent lipid-lowering and hepatoprotective activity
    Quan, Lina
    Guo, Ying
    Wang, Siyao
    Sun, Mengfei
    Pang, Yan
    Cui, Chunli
    Wang, Jinrui
    Wei, Jinlian
    Wei, Peifeng
    Xie, Yundong
    MEDICINAL CHEMISTRY RESEARCH, 2024, 33 (05) : 796 - 810
  • [33] Euphylonoids A and B, Two Highly Modified Jatrophane Diterpenoids with Potent Lipid-Lowering Activity from Euphorbia hylonoma
    Wu, Shu-Qi
    Fan, Run-Zhu
    Yuan, Fang-Yu
    Li, Wei
    Huang, Dong
    Li, Shen
    Tang, Gui-Hua
    Huang, Zhi-Shu
    Yin, Sheng
    ORGANIC LETTERS, 2022, 24 (48) : 8854 - 8858
  • [34] Novel Pyrrole Derivatives as Potent lipid-Lowering Agents in Triton-WR-1339-Induced Hyperlipidemic Rats
    Shattat, Ghassan F.
    Abuskeika, Ghassan M.
    Al-Qirim, Tariq M.
    Huwaitat, Rawan
    El-Huneidi, Waseem
    Abu Khalaf, Reema
    Al-Hiari, Yusuf M.
    Jasim, Suhair H.
    Hamadaneh, Lama
    LATIN AMERICAN JOURNAL OF PHARMACY, 2015, 34 (06): : 1258 - 1264
  • [35] Prostate cancer and serum PSA among users of serum lipid-lowering drugs in the Finnish prostate cancer screening trial
    Murtola, T.
    Tammela, T.
    Maeaettaenen, L.
    Auvinen, A.
    EUROPEAN UROLOGY SUPPLEMENTS, 2007, 6 (02) : 223 - 223
  • [36] Differences Between Rosuvastatin and Atorvastatin in Lipid-Lowering Action and Effect on Glucose Metabolism in Japanese Hypercholesterolemic Patients With Concurrent Diabetes - Lipid-Lowering With Highly Potent Statins in Hyperlipidemia With Type 2 Diabetes Patients (LISTEN) Study
    Ogawa, Hisao
    Matsui, Kunihiko
    Saito, Yoshihiko
    Sugiyama, Seigo
    Jinnouchi, Hideaki
    Sugawara, Masahiro
    Masuda, Izuru
    Mori, Hisao
    Waki, Masako
    Yoshiyama, Minoru
    Watada, Hirotaka
    CIRCULATION JOURNAL, 2014, 78 (10) : 2512 - 2515
  • [37] Lipid-lowering effect of maize-based traditional Mexican food on a metabolic syndrome model in rats
    Munoz Cano, Juan Manuel
    Carrillo Aguilar, Andrea
    Cordova Hernandez, Juan
    LIPIDS IN HEALTH AND DISEASE, 2013, 12
  • [38] Lipid-lowering effect of maize-based traditional Mexican food on a metabolic syndrome model in rats
    Juan Manuel Muñoz Cano
    Andrea Carrillo Aguilar
    Juan Córdova Hernández
    Lipids in Health and Disease, 12
  • [39] CHANGES IN SERUM LIPOPROTEIN(A) IN HYPERLIPIDEMIC SUBJECTS UNDERGOING LONG-TERM TREATMENT WITH LIPID-LOWERING DRUGS
    PRASAD, M
    GOLDBERG, A
    GUCCIONE, M
    HOOVER, DR
    DOBS, AS
    CLINICAL RESEARCH, 1994, 42 (03): : A456 - A456
  • [40] Serum adiponectin is decreased in patients with familial combined hyperlipidemia and normolipaemic relatives and is influenced by lipid-lowering treatment
    Arca, M.
    Cambuli, V. M.
    Montali, A.
    Sentinelli, F.
    Filippi, E.
    Campagna, F.
    Quagliarini, F.
    Antonini, R.
    Romeo, S.
    Baroni, M. G.
    NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2009, 19 (09) : 660 - 666